SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Elizabeth I — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientElizabeth Tudor
Date of birth1533-09-17
IdentifiersMRN HR-RE003-SYN-TD; SSN (made up) 000-03-5529
Document date1603-03-16
AuthorPhilippa Ashcombe-Nwosu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Seven-week depression treatment review. [S]

History of Present Illness

Ms. Tudor returns seven weeks after starting sertraline, now six weeks at 50 mg. She has had six sessions of interpersonal psychotherapy and has been able, for the first time, to talk about the friend she lost two years ago and her part in the breach between them. Her mood is lighter on most days; she has resumed audiences on most mornings, played music twice, and seen two old friends. She sleeps about five and a half hours. Her new partial denture is to be fitted next week, and she eats more, though still slowly. She has had no side effects, no falls, and no thoughts of death or self-harm. [S]

ElementDetail
MedicationSertraline 50 mg for six weeks; no side effects
PsychotherapySix IPT sessions, focused on grief
SleepAbout five and a half hours; Insomnia Severity Index 11
FunctionAudiences most mornings; music and friends again
SafetyNo suicidal thoughts
PHQ-98, down from 17

Review of Systems

SystemResultFinding
ConstitutionalPositiveAppetite better; weight 53.4 kg
GastrointestinalNegativeNo nausea, diarrhea, or bleeding
MusculoskeletalNegativeNo falls; shoulder ache settled
PsychiatricPositiveMood lighter but not yet back to her usual; no suicidal thoughts, elevated mood, or agitation

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Diphenhydramine 25 mg oral capsule (over the counter), one or two capsules at bedtime for sleepOne or two capsules at bedtimeOral route1602-12-01 to 1603-01-12completedS
Sertraline 25 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route1603-01-26 to 1603-02-02completedS
Sertraline 50 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route1603-02-02activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for throat pain or fever, no more than 3 g a dayTwo tablets every 6 hours as needed; no more than six tablets a dayOral route1603-02-02 to 1603-02-23completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1603-03-16Body height163cmS
1603-03-16Body weight53.4kgS
1603-03-16Body mass index (BMI) [Ratio]20.1kg/m2S
1603-03-16Systolic blood pressure124mm[Hg]S
1603-03-16Diastolic blood pressure72mm[Hg]S
1603-03-16Heart rate70/minS
1603-03-16Respiratory rate14/minS
1603-03-16Body temperature36.5CelS
1603-03-16Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1603-03-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
1603-03-16Geriatric depression scale (GDS) short version total4{score}S

Physical Exam

Vital signs recorded on 1603-03-16; see the Vital Signs section. [S]

SystemFinding
GeneralThin but better nourished; animated
Mental statusWarm and engaged; normal pace of speech; mood "much lighter"; affect reactive; no suicidal ideation; no psychotic features
CardiovascularBlood pressure 124/72 mmHg seated, no orthostatic drop; pulse 70
MusculoskeletalTimed Up and Go 10 seconds

Problems

ProblemClinical statusVerificationCodeProvenance
Low mood, sleeplessness (about four hours a night), poor appetite, and unintended loss of 3.5 kg (6 percent) over three months, after bereavements and in a demanding public role; under evaluation for depression and medical causesresolvedconfirmed R45.89S — Synthetic presenting concern at the index visit, echoing the documented low spirits and poor appetite of her last months; superseded by the depression diagnosis at the second visit.
Major depressive disorder, single episode, moderate (PHQ-9 17 and GDS-15 10 at intake), in an older woman after bereavements; medical causes excludedactiveconfirmed F32.1S — Synthetic modern diagnosis. Her deep melancholy, sleeplessness, and refusal of food in her last months are documented (D); calling them major depression is a modern reading, and no diagnosis was made in her lifetime.
Chronic insomnia comorbid with depression: sleep-maintenance and early-morning waking for three months, Insomnia Severity Index 19activeconfirmed G47.00S — Synthetic diagnosis echoing the documented sleeplessness of her last months.
Partial loss of teeth with an ill-fitting upper partial denture and painful chewing, contributing to poor intakeactiveconfirmed K08.409S — Synthetic dental finding echoing the documented description of her teeth; no cause is asserted.
One fall in the past year (a stumble boarding a boat, with bruised shins) and low body weight; fall riskactiveconfirmed Z91.81S — Synthetic fall-risk problem anchored to her documented stumble and fall in December 1602.
Acute viral pharyngitis with a low-grade fever, cough, and runny nose; no features of streptococcal infection or a peritonsillar abscess; resolvedresolvedconfirmed J02.9S — Synthetic intercurrent illness at an unscheduled visit; it echoes the documented cold of January 1603 (CLM-0012) and asserts no cause for the inflammation and throat symptoms reported later.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPHQ-9Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today8, down from 17 (53 percent): response; remission is PHQ-9 below 5
SurveyGDS-15Baseline and to monitor response in adults 65 or older (monthly here)Completed today4, below the cutoff of 5
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)Every visit during active treatmentCompleted todayNo suicidal thoughts, intent, plan, or behavior; PHQ-9 item 9 scored 0
LaboratorySodium on an SSRIAfter starting, after dose increases, and with symptomsNot indicated136 mmol/L four weeks after starting; no dose change and no confusion, nausea, or unsteadiness
Medication safetyAdherence and adverse-effect reviewEvery visit during active treatmentCompleted todayNo missed doses; no side effects
ReferralInterpersonal psychotherapyWeeklyCompleted todaySix sessions; grief focus
ExaminationWeight and nutritionEvery visit while weight is below her usualCompleted today53.4 kg, up 1.0 kg since the diagnosis visit; usual weight 55.9 kg
ExaminationFall risk on an SSRI: orthostatic blood pressure, gait, and falls since the last visitAt baseline, after starting an SSRI, and with dose changesCompleted todayNo falls; no orthostatic drop; Timed Up and Go 10 seconds
ImagingDXA of the hip and spineOnce for women 65 or older; ordered at the wellness visitDueBooked for next week; no result yet
Self-managementSleep (CBT-I), activity, and social contactEvery visit during active treatmentCompleted todayInsomnia Severity Index 11; audiences, music, and friends resumed
LaboratoryLithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS)Only on those drugsNot indicatedTreated with an SSRI only

Goal progress:

Guideline basis: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016); Osteoporosis to Prevent Fractures: Screening (2025)

Follow-up: Depression review in four weeks, at about twelve weeks of treatment. [S]